- Home
- AON vs ZTS Comparison
AON vs ZTS Comparison
Compare AON & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AON
- ZTS
- Stock Information
- Founded
- AON 1919
- ZTS 1952
- Country
- AON Ireland
- ZTS United States
- Employees
- AON N/A
- ZTS N/A
- Industry
- AON Specialty Insurers
- ZTS Biotechnology: Pharmaceutical Preparations
- Sector
- AON Finance
- ZTS Health Care
- Exchange
- AON Nasdaq
- ZTS Nasdaq
- Market Cap
- AON 84.3B
- ZTS 80.4B
- IPO Year
- AON N/A
- ZTS 2013
- Fundamental
- Price
- AON $358.57
- ZTS $163.87
- Analyst Decision
- AON Hold
- ZTS Strong Buy
- Analyst Count
- AON 16
- ZTS 9
- Target Price
- AON $354.75
- ZTS $220.33
- AVG Volume (30 Days)
- AON 1.2M
- ZTS 2.6M
- Earning Date
- AON 01-31-2025
- ZTS 02-11-2025
- Dividend Yield
- AON 0.75%
- ZTS 1.05%
- EPS Growth
- AON N/A
- ZTS 8.38
- EPS
- AON 11.69
- ZTS 5.32
- Revenue
- AON $14,926,000,000.00
- ZTS $9,152,000,000.00
- Revenue This Year
- AON $18.95
- ZTS $9.48
- Revenue Next Year
- AON $11.19
- ZTS $4.92
- P/E Ratio
- AON $30.68
- ZTS $31.00
- Revenue Growth
- AON 13.67
- ZTS 9.33
- 52 Week Low
- AON $268.06
- ZTS $144.80
- 52 Week High
- AON $395.33
- ZTS $200.53
- Technical
- Relative Strength Index (RSI)
- AON 37.13
- ZTS 29.38
- Support Level
- AON $352.36
- ZTS $163.37
- Resistance Level
- AON $364.64
- ZTS $181.85
- Average True Range (ATR)
- AON 5.66
- ZTS 3.88
- MACD
- AON -2.64
- ZTS -1.22
- Stochastic Oscillator
- AON 16.53
- ZTS 5.06
About AON Aon plc (Ireland)
Aon is a leading global provider of insurance and reinsurance brokerage and human resources solutions. Its operations are tilted toward its brokerage operations. Headquartered in London, Aon has about 50,000 employees and operations in over 120 countries.
About ZTS Zoetis Inc.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.